Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface - PubMed (original) (raw)
Review
Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface
Holger K Eltzschig et al. Trends Cardiovasc Med. 2008 Apr.
Abstract
Nucleotide signaling is currently an area of intense investigation. Extracellular adenosine triphosphate (ATP) liberated during hypoxia or inflammation can either signal directly to purinergic receptors or, after phosphohydrolytic metabolism, can activate surface adenosine receptors. Given the association of polymorphonuclear leukocytes (PMNs) with adenine nucleotide/nucleoside signaling in the inflammatory milieu, it was recently demonstrated that PMNs actively release ATP via a connexin 43 hemichannel-dependent mechanism. Here, we review the mechanisms of ATP release and subsequent functional implications of ATP metabolism at the interface between PMN and vascular endothelial cells during inflammation and in hypoxia.
Figures
Figure 1
Model of PMN — endothelial crosstalk by extracellular nucleotides. At sites of hypoxia or ongoing inflammation, activated PMN provide an extracellular source of ATP through membrane Cx43 hemichannels. ATP released in this fashion is metabolized through two enzymatic steps and results in the liberation of extracellular adenosine. Adenosine generated through this pathway is available for activation of surface endothelial adenosine receptors, particularly the AdoA2BR. Diminished oxygen supply (hypoxia) at sites of inflammation coordinates the induction of CD39, CD73 and AdoA2BR. At such sites, post-receptor increases in intracellular cyclic AMP result in enhanced barrier function. This biochemical crosstalk mechanism may provide an innate mechanism to preserve vascular integrity and attenuate vascular leak. This model is adapted with permission from published work (Eltzschig et al. 2003).
Similar articles
- ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function.
Eltzschig HK, Eckle T, Mager A, Küper N, Karcher C, Weissmüller T, Boengler K, Schulz R, Robson SC, Colgan SP. Eltzschig HK, et al. Circ Res. 2006 Nov 10;99(10):1100-8. doi: 10.1161/01.RES.0000250174.31269.70. Epub 2006 Oct 12. Circ Res. 2006. PMID: 17038639 - Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors.
Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, Colgan SP. Eltzschig HK, et al. J Exp Med. 2003 Sep 1;198(5):783-96. doi: 10.1084/jem.20030891. Epub 2003 Aug 25. J Exp Med. 2003. PMID: 12939345 Free PMC article. - Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.
Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP. Eltzschig HK, et al. Blood. 2004 Dec 15;104(13):3986-92. doi: 10.1182/blood-2004-06-2066. Epub 2004 Aug 19. Blood. 2004. PMID: 15319286 - Nucleotide metabolism and cell-cell interactions.
Eltzschig HK, Weissmüller T, Mager A, Eckle T. Eltzschig HK, et al. Methods Mol Biol. 2006;341:73-87. doi: 10.1385/1-59745-113-4:73. Methods Mol Biol. 2006. PMID: 16799190 Review. - Purinergic Regulation of Neutrophil Function.
Wang X, Chen D. Wang X, et al. Front Immunol. 2018 Mar 1;9:399. doi: 10.3389/fimmu.2018.00399. eCollection 2018. Front Immunol. 2018. PMID: 29545806 Free PMC article. Review.
Cited by
- The resurgence of A2B adenosine receptor signaling.
Aherne CM, Kewley EM, Eltzschig HK. Aherne CM, et al. Biochim Biophys Acta. 2011 May;1808(5):1329-39. doi: 10.1016/j.bbamem.2010.05.016. Epub 2010 May 28. Biochim Biophys Acta. 2011. PMID: 20546702 Free PMC article. Review. - Alternative adenosine Receptor activation: The netrin-Adora2b link.
Yuan X, Mills T, Doursout MF, Evans SE, Vidal Melo MF, Eltzschig HK. Yuan X, et al. Front Pharmacol. 2022 Jul 15;13:944994. doi: 10.3389/fphar.2022.944994. eCollection 2022. Front Pharmacol. 2022. PMID: 35910389 Free PMC article. Review. - Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention.
Visternichan O, Jalali SF, Taizhanova D, Muravlyova L, Igimbayeva G. Visternichan O, et al. Caspian J Intern Med. 2019 Winter;10(1):86-91. doi: 10.22088/cjim.10.1.86. Caspian J Intern Med. 2019. PMID: 30858946 Free PMC article. - Changes in Neutrophil Metabolism upon Activation and Aging.
Richer BC, Salei N, Laskay T, Seeger K. Richer BC, et al. Inflammation. 2018 Mar;41(2):710-721. doi: 10.1007/s10753-017-0725-z. Inflammation. 2018. PMID: 29322364 - Perish in the Attempt: Regulated Cell Death in Regenerative and Nonregenerative Tissue.
Li S, Tao G. Li S, et al. Antioxid Redox Signal. 2023 Dec;39(16-18):1053-1069. doi: 10.1089/ars.2022.0166. Epub 2023 Jul 18. Antioxid Redox Signal. 2023. PMID: 37218435 Free PMC article. Review.
References
- Bao X, Reuss L, Altenberg GA. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of Serine 368. J Biol Chem. 2004;279:20058–20066. Epub 22004 Feb 20017. - PubMed
- Boeck CR, Bronzatto MJ, Souza DG, et al. The modulation of ecto-nucleotidase activities by glutamate in cultured cerebellar granule cells. Neuroreport. 2000;11:709–712. - PubMed
- Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003;17:2614–2623. - PubMed
- Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337–1340. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R29 DK050189-05/DK/NIDDK NIH HHS/United States
- P01 DE013499-050003/DE/NIDCR NIH HHS/United States
- DK 50189/DK/NIDDK NIH HHS/United States
- P50 DE016191/DE/NIDCR NIH HHS/United States
- DE 016191/DE/NIDCR NIH HHS/United States
- R29 DK050189/DK/NIDDK NIH HHS/United States
- HL 60569/HL/NHLBI NIH HHS/United States
- R37 DK050189/DK/NIDDK NIH HHS/United States
- P01 DE013499-010003/DE/NIDCR NIH HHS/United States
- P01 DE013499-02S10003/DE/NIDCR NIH HHS/United States
- R01 HL060569-10A2/HL/NHLBI NIH HHS/United States
- P01 DE013499-030003/DE/NIDCR NIH HHS/United States
- R01 HL060569/HL/NHLBI NIH HHS/United States
- R01 DK050189/DK/NIDDK NIH HHS/United States
- P01 DE013499/DE/NIDCR NIH HHS/United States
- P01 DE013499-040003/DE/NIDCR NIH HHS/United States
- R01 HL060569-09/HL/NHLBI NIH HHS/United States
- P01 DE013499-020003/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources